MRNS
Price
$0.25
Change
-$0.00 (-0.00%)
Updated
Dec 18, 04:22 PM (EDT)
83 days until earnings call
PHVS
Price
$18.50
Change
+$0.01 (+0.05%)
Updated
Dec 18, 04:59 PM (EDT)
127 days until earnings call
Ad is loading...

MRNS vs PHVS

Header iconMRNS vs PHVS Comparison
Open Charts MRNS vs PHVSBanner chart's image
Marinus Pharmaceuticals
Price$0.25
Change-$0.00 (-0.00%)
Volume$600
CapitalizationN/A
Pharvaris
Price$18.50
Change+$0.01 (+0.05%)
Volume$4.8K
CapitalizationN/A
MRNS vs PHVS Comparison Chart
Loading...
MRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRNS vs. PHVS commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRNS is a Hold and PHVS is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (MRNS: $0.25 vs. PHVS: $18.49)
Brand notoriety: MRNS and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRNS: 20% vs. PHVS: 50%
Market capitalization -- MRNS: $13.63M vs. PHVS: $1B
MRNS [@Biotechnology] is valued at $13.63M. PHVS’s [@Biotechnology] market capitalization is $1B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRNS’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • MRNS’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, both MRNS and PHVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRNS’s TA Score shows that 5 TA indicator(s) are bullish while PHVS’s TA Score has 3 bullish TA indicator(s).

  • MRNS’s TA Score: 5 bullish, 3 bearish.
  • PHVS’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, MRNS is a better buy in the short-term than PHVS.

Price Growth

MRNS (@Biotechnology) experienced а -17.34% price change this week, while PHVS (@Biotechnology) price change was +1.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

MRNS is expected to report earnings on Mar 11, 2025.

PHVS is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1B) has a higher market cap than MRNS($13.6M). PHVS YTD gains are higher at: -34.082 vs. MRNS (-97.728). MRNS (-122.86M) and PHVS (-127.53M) have comparable annual earnings (EBITDA) . PHVS has more cash in the bank: 305M vs. MRNS (42.2M). PHVS has less debt than MRNS: PHVS (117K) vs MRNS (56M). MRNS has higher revenues than PHVS: MRNS (31.5M) vs PHVS (0).
MRNSPHVSMRNS / PHVS
Capitalization13.6M1B1%
EBITDA-122.86M-127.53M96%
Gain YTD-97.728-34.082287%
P/E RatioN/AN/A-
Revenue31.5M0-
Total Cash42.2M305M14%
Total Debt56M117K47,863%
FUNDAMENTALS RATINGS
MRNS: Fundamental Ratings
MRNS
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRNSPHVS
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 15 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
MRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DAREX14.57-0.07
-0.48%
Dunham Real Estate Stock A
NWHVX13.79-0.12
-0.86%
Nationwide Geneva Mid Cap Gr A
JMVAX15.89-0.14
-0.87%
Janus Henderson Mid Cap Value I
JMVRX37.79-0.37
-0.97%
JPMorgan Mid Cap Value R5
STSAX7.40-0.10
-1.33%
Allspring Common Stock C

MRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRNS has been loosely correlated with AXON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MRNS jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRNS
1D Price
Change %
MRNS100%
-0.28%
AXON - MRNS
40%
Loosely correlated
-2.09%
NTLA - MRNS
39%
Loosely correlated
-1.87%
FOLD - MRNS
36%
Loosely correlated
-0.10%
AMRN - MRNS
35%
Loosely correlated
-0.80%
SAGE - MRNS
33%
Poorly correlated
-1.40%
More